News from the MCRC
Partner News
23/11/2022
Precision medicine trial opens for rare adult and paedIatric cancers
Cancer Research UK, The University of Manchester and Roche Products Ltd (‘Roche’) have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options.
Partner News
22/11/2022
STRONG AYA research project for adolescents and young adults with cancer launches
Funded by UKRI and EU HORIZON support, STRONG AYA joins fourteen European centres for care, research and advocacy to improve research and healthcare for adolescents and young adults (AYA) with cancer.
Partner News
22/11/2022
Lean Life Science and Cancer Research UK Launch the Oncology Development Programme
The new development programme aims to accelerate development of high impact novel cancer innovations
Podcast
21/11/2022
Season One now available – One in Two: A Manchester Cancer Research Podcast
MCRC Blog
16/11/2022
The Health Economics of Cancer Care
We speak to Dr Alex Thompson, a Senior Research Fellow based at the Manchester Centre for Health Economics (MCHE) about the importance of health economics within the cancer care continuum.
Director's Update
02/11/2022
MCRC Director’s Update – October 2022
Partner News
14/10/2022
Greater Manchester awarded its largest ever research funding to tackle health inequalities and drive health improvements across the city region
The NIHR Manchester BRC has received a £59.1million award to translate its scientific discoveries into new treatments, diagnostic tests, and medical technologies to improve patients’ lives in Greater Manchester, and beyond, over the next five years.
MCRC Blog
13/10/2022
Cakes and Cycles: Fundraising for Re-Write Cancer
Partner News
12/10/2022
Groundbreaking Manchester partnership with Kenyan oesophageal cancer initiative gets £2.6m award
Research Spotlight
05/10/2022
How can we encourage the UK public to stop indoor tanning?
Research Spotlight
04/10/2022
Gene mutations should be tested routinely for ovarian cancer, say scientists
Scientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithelial ovarian cancer risk of between 5% and 20% has a much higher than expected detection rate.
Director's Update
30/09/2022
MCRC Director’s Update – September 2022
Impact Case Study
Changing clinical practice for patients with Lymphoma
We hear from Professor John Radford and Professor Tim Illidge who have been leading international research efforts in both Hodgkin and non-Hodgkin lymphoma.
Podcast
23/09/2022
One in Two: A Manchester Cancer Research Podcast
Available now, our new podcast gives researchers a new platform to speak about their research.
